12-2115386-C-T
Variant summary
Our verdict is Benign. Variant got -13 ACMG points: 1P and 14B. PP2BP4_ModerateBP6_Very_StrongBS2
The NM_000719.7(CACNA1C):c.212C>T(p.Ala71Val) variant causes a missense change. The variant allele was found at a frequency of 0.0000746 in 1,608,932 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. A71A) has been classified as Benign.
Frequency
Consequence
NM_000719.7 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -13 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CACNA1C | NM_000719.7 | c.212C>T | p.Ala71Val | missense_variant | 2/47 | ENST00000399655.6 | NP_000710.5 | |
CACNA1C | NM_001167623.2 | c.212C>T | p.Ala71Val | missense_variant | 2/47 | ENST00000399603.6 | NP_001161095.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CACNA1C | ENST00000399603.6 | c.212C>T | p.Ala71Val | missense_variant | 2/47 | 5 | NM_001167623.2 | ENSP00000382512 | ||
CACNA1C | ENST00000399655.6 | c.212C>T | p.Ala71Val | missense_variant | 2/47 | 1 | NM_000719.7 | ENSP00000382563 |
Frequencies
GnomAD3 genomes AF: 0.0000985 AC: 15AN: 152234Hom.: 0 Cov.: 34
GnomAD3 exomes AF: 0.000104 AC: 25AN: 239394Hom.: 0 AF XY: 0.000107 AC XY: 14AN XY: 130816
GnomAD4 exome AF: 0.0000721 AC: 105AN: 1456698Hom.: 0 Cov.: 32 AF XY: 0.0000690 AC XY: 50AN XY: 724512
GnomAD4 genome AF: 0.0000985 AC: 15AN: 152234Hom.: 0 Cov.: 34 AF XY: 0.0000941 AC XY: 7AN XY: 74368
ClinVar
Submissions by phenotype
Long QT syndrome Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 30, 2023 | - - |
Cardiovascular phenotype Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 25, 2022 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at